References
- Vikram B, Malamud S, Gold J, Nussbaum M, Kimmelman C, Lucente F, Pavlou W, Pisch J, Chadha M, Beattie E. Chemotherapy rapidly alternating with accelerated radiotherapy for advanced carcinomas of the hypopharynx and upper esophagus: A feasibility study. Head Neck 1991; 13: 415–419
- Malamud S, Vikram Gold B. J. Rapidly alternating chemoiradiotherapy in locally advanced cancer. Proc Am Soc Clin Oncol 1989; 8: 174
- Looney W B. Special Lecture: Alternating chemotherapy and radiotherapy. NCI Monogr 1988; 8: 85–94
- Vikram B. Accelerated, interrupted twice a day radiation therapy decreases acute mucosal toxicity. Int J Radiat Oncol Biol Phys 1987; 13: 1971
- Merlano M, Vitale V, Rosso R, Benasso M, Corvo R, Cavallari M, Sanguinetti G, Bacigalupo A, Badellino F, Margarino G, Brema F, Pastorino G, Marziano C, Grimaldi A, Scasso F, Sperati G, Pallestrini E, Garaventa G, Accomando E, Cordone G, Comella G, Daponte A, Rubagotti A, Bruzzi P, Santi L. Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115–1121
- Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–1598
- Fushiki M, Abe M. Randomized double-blind controlled study of rhg-csf in patients with neutropenia induced by radiation therapy. Proc Am Soc Clin Oncol 1992; 11: 410, (abstract)
- Bunn P A, Crowley J, Hazuka M, Tolley R, Livingston R. The role of GM-CSF in limited stage SCLC: A randomized phase III study of the Southwest Oncology Group (SWOG). Proc Am Soc Clin Oncol 1992; 11: 292, (abstract)
- Momin F, Kraut M, Lattin P, Valdivieso M. Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1992; 11: 294, (abstract)
- Tepler I, Cannistra S, Anderson K. Use of peripheral blood progenitor cells (PBPC) for support of repetitive high-dose carboplatin chemotherapy (x4) in previously untreated outpatients with cancer. Blood 1992; 82: 71a, (Suppl 1)
- Brugger W, Birken R, Bertz H, Presslerl K, Mertelsmann R, Kanz L. Chemotherapy plus G-CSF mobilised peripheral blood progenitor cells accelerate both neutrophil and platelet recovery after high-dose etoposide, ifosofamide and cisplatin. Blood 1992; 82: 519a, (Suppl 1)
- Kritz A, Crown J, Motzer R. Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus GM-CSF: A randomized trial. Cancer 1993; 71: 2515–2521
- Hishikawa Y, Kurisu K, Taniguchi M, Kamikonya N, Miura T. High-dose-rate intraluminal brachytherapy for esophageal cancer: 10 years experience in Hyogo College of Medicine. Radiother Oncol 1991; 21: 107–114
- Sur R K, Singh D P, Sharma S C, Singh M T, Kochhar R, Negi P S, Sethi T, Patel F, Ayyagari S, Bhatia S P. Radiation therapy of esophageal cancer: Role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1992; 22: 1043–1046
- El-Badawi S A, Goepfert H, Fletcher G H, Herson J, Oswald M J. Squamous cell carcinoma of the pyriforrn sinus. Laryngoscope 1982; 92: 357–364
- Kirchner J A, Owen J R. Five hundred cancers of the larynx and pyriform sinus. Results of treatment by radiation and surgery. Laryngoscopy 1977; 87: 1288–1303
- Vikram B, Bod G, Pfister D. New strategies for avoiding total laryngectomy in patients with head and neck cancer. NCI Monogr 1988; 6: 361–364
- Wendt T, Hartenstein R, Wustrow T, Lissner J. Cisplatin fluorouracil with leucovorin calcium enhancement and synchronous accelerated radiotherapy in the management of locally advanced head and neck, a phase II study. J Clin Oncol 1989; 7: 471–476